Portfolio company
Pharmacyclics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Principia Biopharma
The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.
Biopharmaceutical company
This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.
Pharmasset
This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.
Acerta Pharma
This biopharmaceutical company develops covalent binding medicines for patients with blood cancers and autoimmune diseases.
ArQule
This biopharmaceutical company develops targeted small molecule drug candidates to treat cancers and rare diseases for patients with unmet medical needs.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Frontier Medicines
This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.
Apexian Pharmaceuticals
This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.
